ResApp (ASX:RAP) receives TGA approval for ResAppDx-EU version 2
- ResApp (RAP) has received Australian Therapeutic Good Administration (TGA) approval for version 2 of its smartphone app
- This app uses machine learning algorithms that analyse a patient's cough sounds to diagnose diseases and provide timely and accurate information
- Adults are now able to use the device to test for respiratory problems in addition to children and infants
Receives TGA approval for ResAppDx-EU version 2
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #